Scientific and Financial Sensation: Moderna and Merck on the Verge of Finding mRNA Cancer Vaccine
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Modern (MRNA.O) and Merck (MRK.N) announced that a mRNA personalized cancer vaccine reduced the risk of recurrence and spread of melanoma in a clinical trial in the phase of...
Jean-Marc Sabatier analyses Moderna's announcements about a personalized messenger RNA vaccine against melanoma. He recalls that it is essentially a preventive treatment of recidivism, and not a treatment of a cancer currently present: the tumors have been surgically removed. The principle consists of analyzing the tumor of each patient, identifying his [...] The article Moderna vaccine at mRNA n ,is neither a vaccine nor a cure for cancer, dixi…
Moderna's stock, which launched a coronavirus vaccine, jumped 180 percent on the same day.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
